Skip to main content
SpringerLink
Log in

Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy

  • Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Abstract

The relationships between some genetic markers, as evaluated by DNA analysis, and ultrasound evidence of extracoronary athero-sclerosis, as detected by ultrasound methods, were evaluated in 39 myocardial infarction survivors of middle age and in 40 healthy controls of comparable age. Coronary heart disease (CHD) patients showed higher levels of triglycerides (P = 0.01) and greater number of exsmokers (P = 0.004). Carotid stenoses (> 15%) were detected in ten CHD patients and in two controls; iliac stenoses (> 15%) or abnormal ankle/arm ratio (< 0.97) were found in ten CHD patients and in one control; the scores of vascular disease severity in the myocardial infarction survivors were higher (Mann-Whitney test) than in controls (P < 0.01). Molecular genetic analysis of Sstl restriction fragment length polymorphism (RFLP) of the apolipoprotein (apo) AI-CIII cluster and of the apo B gene demonstrated a higher frequency of the S2 allele (SstI RFLP) in coronary patients than in controls (P = 0.04) and no significant differences in the frequencies of XbaI RFLP of the apo B gene between patients and controls. The relative risk of myocardial infarction associated with an abnormal vascular score (> 8) or with the presence of the rare allele S2 (SstI apo AI-CIII polymorphism) was estimated by odds ratios. The lower 95% limits of odds ratios were above 1 (indicating significant increase in the relative risk of myocardial infarction) both in the case of vascular score and that of SstI RFLP. These associations were independent of one another and of triglyceride levels. SstI RFLP association with CHD disappeared after adjustment for smoking habits. Ultrasound evidence of extracoronary atherosclerosis and SstI RFLP are markers of cardiovascular risk, which might be of help in identifying coronary-prone individuals, independently of the influence of life-style changes or ongoing treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

apo:

apolipoprotein

CHD:

coronary heart disease

HDL:

high-density lipoprotein

LDL:

low-density lipoprotein

PCR:

polymerase chain reactions

RFLP:

restriction fragment length polymorphism

VLDL:

very low density lipoprotein

References

  1. Aalto-Setala K, Kontula K, Sane T,Nieminen M, Nikkila E (1987) DNA polymorphism of apolipoprotein A-I/CIII and insulin genes in familial hypertriglyceridaemia and coronary heart disease. Atherosclerosis 66:145–152

    Google Scholar 

  2. Aalto-Setala K, Tikkanen MJ, Taskinen MR, Nieminen M, Holmberg P, Kontula K (1988) XbaI and c/g polymorphism of apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland. Atherosclerosis 74:47–54

    Google Scholar 

  3. Anderson RA, Wallace RB (1985) Apoprotein A-I linked genetic polymorphism associated with high density lipoprotein levels. Clin Res 33:15

    Google Scholar 

  4. Austin AM (1991) Plasma triglyceride and coronary heart Disease. Arterioscler Thromb 11:2–14

    Google Scholar 

  5. Babirak SP, Iverius PH, Fujimoto WY, Brunzell JD (1989) The detection of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 9:326–334

    Google Scholar 

  6. Ballantyne FC, Clark RS, Simpson HS, Ballantyne D (1982) High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism 31:433–437

    Google Scholar 

  7. Carlsson P, Darnfors C, Oloffson SO, Bjursell G (1986) Analysis of human apolipoprotein B gene: complete structure of the B-74 region. Gene 49:29–51

    Google Scholar 

  8. Carter S (1968) Indirect systolic pressures and pulse waves in arterial occlusive disease of the lower extremities. Circulation 37:624–637

    Google Scholar 

  9. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Crouse JR (1990) Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study. Circulation 82:1230–1242

    Google Scholar 

  10. Criqui MH, Langer RD, Frorek A, Feigelson HS, Klauber MR, McCann TJ, Browner D (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. New Engl J Med 326:381–386

    Google Scholar 

  11. Darnfors C, Wiklund O, Nilsson J, Gerard B, Carlsson P, Johansson S, Bondjers G, Bjursell G (1989) Lack of correlation between the apolipoprotein B XbaI polymorphism and blood lipid levels in a Swedish population. Atherosclerosis 75:183–188

    Google Scholar 

  12. Ferns GAA, Ritchie C, Stocks J, Galton DJ (1985) Genetic polymorphism of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet 11:300–303

    Google Scholar 

  13. Ferns GAA, Lanham J, Dieppe P, Galton DJ (1988) A DNA polymorphism of an apoprotein gene associates with hyper-triglyceridaemia or primary gout. Hum Genet 78:55–59

    Google Scholar 

  14. Genest JJ, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD, Salem DN, Wilson PWF, Masharani U, Frossard PM, Schaefer EJ (1990) DNA polymorphism of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 82:7–17

    Google Scholar 

  15. Gotto AM (1978) Status report: plasma lipids, lipoproteins and coronary heart disease. Atherosclerosis Rev 4:17–28

    Google Scholar 

  16. Gotto AM (1990) Apolipoprotein mutations and markers for coronary heart disease. Curr Opin Lipidol 1:358–366

    Google Scholar 

  17. Hamsten A, De Faire U (1989) Risk factors for coronary artery disease in families of young men with myocardial infarction. Am J Cardiol 59:14–19

    Google Scholar 

  18. Hegele RA, Huang Li-S, Herbert P, Blum C, Buring JE, Hennekens CH, Breslow JL (1986) Apolipoprotein B gene DNA polymorphism associated with myocardial infarction. New Engl J Med 315:1509–1515

    Google Scholar 

  19. Henderson HE, Landon SV, Michie J, Berger GMB (1987) Association of DNA polymorphism in the apolipoprotein C-III gene with divers hyperlipidaemic phenotypes. Hum Genet 75:62–65

    Google Scholar 

  20. Hopkins PN, Williams RR (1981)A survey of 246 suggested coronary risk factors. Atheroscler Rev 40:1–52

    Google Scholar 

  21. Karathanasis SK, Zannis VI, Breslow JL (1985) Isolation and characterization ofcDNA clones corresponding to two different human apo C-III alleles. J Lipid Res 26:451–456

    Google Scholar 

  22. Lopes Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882–884

    Google Scholar 

  23. Maniatis T, Fritsh EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory 1–520

  24. Morris SW, Price WH (1985) DNA sequence polymorphism in the apolipoprotein A-I/C-III gene cluster. Lancet II:1127–1128

    Google Scholar 

  25. Myant NB, Gallagher J, Babir M, Thompson GR, Wile D, Humphries SE (1989) Restriction fragment length polymorphism in the apo B gene in relation to coronary artery disease. Atherosclerosis 77:193–201

    Google Scholar 

  26. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bonol MG, Wolfson SK, Bommer W, Price TR, Gardin JM, Savage PJ, on behalf of the CHS Collaborative Research Group (1992) Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 23:1752–1760

    CAS  Google Scholar 

  27. Ordovas JM, Civeira F, Genest J, Craig S, Robbins AH, Meade T, Pocovi M, Frossard PM, Masharani U, Wilson PWF, Salem DN, Ward RH, Schaefer EJ (1991) Restriction fragment length polymorphism of the apolipoprotein A-I, C-III, A-IV gene locus. Atherosclerosis 87:75–86

    CAS  PubMed  Google Scholar 

  28. Price WH, Kitchin AH, Burgon PRS, Morris SW, Wenham PR, Donald PM (1989) DNA restriction fragment length polymorphism as markers of familial coronary heart disease. Lancet II:1407–1411

    Google Scholar 

  29. Protter A, Levy-Wilson B, Miller J, Bencen G, White T, Seilhamer JJ (1984) Isolation and sequence analysis of the human apolipoprotein CHI gene and the intergenic region between the apo AI and apo CHI genes. DNA 3:449–456

    Google Scholar 

  30. Rees A, Stocks J, Shoulders CC, Galton DJ, Baralle FE (1983) Polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet 1:444–446

    Google Scholar 

  31. Rees A., Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, Jowett NI, Baralle FE, Galton DJ (1985) Deoxyribonucleic acid in the apolipoprotein A-1-C-III gene cluster. J Clin Invest 76:1090–1095

    Google Scholar 

  32. Rees A, Stocks J, Williams LG, Caplin JL, Jowett NI, Camm AJ, Galton DJ (1985) DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. Atherosclerosis 58:269–275

    Google Scholar 

  33. Roederer GO, Langlois YE, Jager KA, Lawrence RJ, Primozich JF, Phillips DJ, Strandness DE (1984) A simple spectral parameter for accurate classification of severe carotid disease. Bruit 8:174–178

    Google Scholar 

  34. Rose GA, Blackburn H, Gillum RF, Prineas RJ (1982) Cardiovascular survey methods. WHO Monograph Series 56:162–165

    Google Scholar 

  35. Rubba P, Faccenda F, De Simone B, Riccardi G, Mancini M (1984) Validation of echo-Doppler for detection of iliac artery stenosis or occlusion. Atherosclerosis Rev 12:185–191

    Google Scholar 

  36. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491

    CAS  PubMed  Google Scholar 

  37. Schlesselman JJ (1982) Case-control studies. Design, conduct, analysis. Oxford University Press, New York, Oxford

    Google Scholar 

  38. Seidel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW (1981) Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 19:838–839

    Google Scholar 

  39. Shoulders CC, Ball MJ, Mann JI, Baralle FE (1986) Genetic marker in apolipoprotein AI/CIII gene complex associated with Hypercholesterolaemia. Lancet II:1286

    Google Scholar 

  40. Snedecor GW, Cochran WG (1989) Statistical methods, 8th edn. Iowa State University Press, Ames

    Google Scholar 

  41. Strandness DE (1983) Non invasive evaluation of atherosclerosis: comparison of methods. Arteriosclerosis 3:103–116

    Google Scholar 

  42. Talmud PJ, Barni N, Kessling AM, Carlsson P, Darnfors C, Bjursell G, Galton D, Wynn V, Kirk H, Hayden MR, Humphries SE (1987) Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis 67:81–89

    Google Scholar 

  43. Trembath RC, Thomas DJB, Hendra TJ, Yudkin JS, Galton DJ (1987) Deoxiribonucleic acid polymorphism of the apoprotein AI-CIII-AIV gene cluster and coronary heart disease in non-insulin-dependent diabetes. Br Med J 294:1577–1578

    Google Scholar 

  44. Vella M, Kessling A, Jowett N, Rees A, Stocks J, Wallis S, Galton D (1985) DNA polymorphism flanking the apo A-I and insulin genes and type III hyperlipidaemia. Hum Gen 69:275–276

    Google Scholar 

  45. Walhefeld AW (1974) Triglyceride determination after enzymatic hydrolysis. In: Bergmeyer HV (ed) Methods of enzymatic analysis, vol IV. Verlag Chemie, Weinheim, Academic Press, New York London, pp 1831–1835

    Google Scholar 

  46. Wiklund O, Darnfors C, Bjursell G, Nilsson J, Linden T, Olofsson SO, Wilhelmsen L, Bondjers G (1989) XbaI restriction fragment length polymorphism of apolipoprotein B in Swedish myocardial infarction patients. Eur J Clin Invest 19:255–258

    Google Scholar 

  47. Woiciachovski AP, Farral M, Cullen P, Wilston TME, Bayliss JD, Farren B, Griffin BA, Caslake MJ, Packard CJ, Shepherd K, Thakker R, Scott J (1991) Familial combined hyperlipidemia linked to the apolipoprotein AI-CIII-AIV cluster on chromosome 11g23-q24. Nature 349:161–164

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Internal Medicine and Metabolic Diseases, Policlinico, Via S. Pansini 5, 1-80131, Naples, Italy

    F. De Lorenzo, B. De Simone & P. Rubba

  2. Dipartimento di Biologia e Patologia Cellulare e Molecolare, CEOS, CNR, Medical School, University “Federico II”, Naples, Italy

    A. Monticelli & S. Cocozza

Authors
  1. F. De Lorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Monticelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Cocozza
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. De Simone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Rubba
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Correspondence to: F. De Lorenzo

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Lorenzo, F., Monticelli, A., Cocozza, S. et al. Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy. Clin Investig 72, 435–441 (1994). https://doi.org/10.1007/BF00180517

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00180517

Key words

Search

Navigation